Sensitive spectrofluorimetric determination of the prokinetic drug; Prucalopride succinate, based on supramolecular aggregation approach with evaluation of method greenness: application to content uniformity test.

The prokinetic drug, prucalopride succinate (PCP), was determined using new spectrofluorimetric approach with a highly sensitive, rapid and simple procedure. The method exploited the enhancement of the inherent native fluorescence of PCP by micellar aggregation with sodium lauryl sulfate (SLS) as an anionic surfactant. Different factors that could affect the fluorescence intensity were carefully studied in order to achieve the maximal fluorescence signal. Measurement of the enhanced fluorescence was done at 354 nm after the excitation at 276 nm. The fluorescence intensity - concentration plot was rectilinear in the concentration range of 50-600 ng/mL with detection and quantitation limits of 13.9 and 42.1 ng/mL, respectively. The method underwent validation according to the International Council for harmonisation criteria in order to assess its analytical performance, and promising results were achieved that proved the validity and reliability of the method. Furthermore, the method was employed effectively for the analysis of the cited drug in commercial pharmaceutical tablets.